FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)
Cardiovascular and Renal Drugs Advisory Committee
Holiday Inn
AGENDA
The
committee will discuss class labeling of antihypertensive drugs based on the
proximity of their data to outcome trials
Committee Chair
Cardiovascular
and Renal Drugs Advisory Committee
Conflict
of Interest Statement LT Cathy Groupe, B.S.N.
Executive
Secretary
Cardiovascular
and Renal Drugs Advisory Committee
Recognition of Retiring Acting Director
Cardiovascular
and Renal Drugs Division
of Cardiovascular and Renal Drug Products
Advisory
Committee members
FDA Review Division Presentation:
Acting Director
Office of Drug Evaluation I
For Antihypertensive Drugs Principal Director
Professor of Cardiovascular Medicine and Epidemiology
The George Institute for International Health
The
For Different Drug Classes
For Hypertension Professor of Medicine and Director
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH
(CDER)
Cardiovascular and Renal Drugs Advisory
Committee
AGENDA
Page 2
Antihypertensive Drugs Chairman and Associate Vice President for Research
Claim Based on an Active
Controlled Study?
Introduction Lance
Berman, MD
Medical Director –
Pfizer, Inc.
Methodology and
Analysis Michael
Gaffney, Ph.D.
[Overview] Senior Director – Statistical Research and Consulting
Pfizer, Inc.
Pressure Effects During the Director – Integrative and Behavioral Cardiology Program
Day Matter? The Zena and Michael A. Wiener Cardiovascular Institute
Treating Hypertension Apply to Professor of Pediatrics and Director of the Division
Children? Pediatric Nephrology and Hypertension